Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial

JW Eikelboom, SS Jolly, EP Belley-Cote… - The Lancet …, 2022 - thelancet.com
Background COVID-19 disease is accompanied by a dysregulated immune response and
hypercoagulability. The Anti-Coronavirus Therapies (ACT) inpatient trial aimed to evaluate …

Worldwide perinatal intimate partner violence prevalence and risk factors for post-traumatic stress disorder in women: a systematic review and meta-analysis

X Dai, X Chu, G Qi, P Yuan, Y Zhou… - Trauma, Violence, & …, 2023 - journals.sagepub.com
Post-traumatic stress disorder (PTSD) in women who have experienced perinatal intimate
partner violence (P-IPV) has gradually attracted the attention of psychologists, mental health …

Uric acid en route to gout

W Zhang - Advances in Clinical Chemistry, 2023 - Elsevier
Gout and hyperuricemia (HU) have generated immense attention due to increased
prevalence. Gout is a multifactorial metabolic and inflammatory disease that occurs when …

Colchicine and mortality outcomes in patients with coronavirus disease (COVID-19)

MI Danjuma, R Kaul, T Alyaarabi, B Elsayed… - European Journal of …, 2023 - ejinme.com
One of the therapeutic hallmarks of the ongoing (COVID-19) pandemic has been the
different iterations of successful and sometimes unsuccessful attempts at re-purposing of …

Decoding Post-Viral Fatigue: The Basal Ganglia's Complex Role in Long-COVID

T Rudroff - Neurology International, 2024 - mdpi.com
Long-COVID afflicts millions with relentless fatigue, disrupting daily life. The objective of this
narrative review is to synthesize current evidence on the role of the basal ganglia in long …

[PDF][PDF] Does colchicine reduce mortality in patients with COVID-19 clinical syndrome? An umbrella review of published meta-analyses

MI Danjuma, R Sayed, M Aboughalia, A Hassona… - Heliyon, 2023 - cell.com
Background. Despite significant improvements in both treatment and prevention strategies,
as well as multiple commissioned reviews, there remains uncertainty regarding the survival …

FRAGILE-COLCOVID19: a clinical trial based on early administration of an oral combination of colchicine and prednisone in elderly patients with COVID-19 in geriatric …

J Hernández-Rodríguez, J Durán-Sanclemente… - Clinical Drug …, 2022 - Springer
Background Unprotected and fragile elderly people in nursing homes experienced the
highest mortality rates during the initial coronavirus disease 2019 (COVID-19) pandemic …

The role of colchicine in the management of COVID-19: a Meta-analysis

K Elshiwy, GEED Amin, MN Farres, R Samir… - BMC Pulmonary …, 2024 - Springer
Abstract Background The Coronavirus disease 2019 (COVID-19) pandemic has robustly
affected the global healthcare and economic systems and it was caused by coronavirus-2 …

Miocarditis por SARS-CoV-2. Una breve revisión

NL Cahuapaza-Gutierrez, TS Campos-Escalante - REC: CardioClinics, 2023 - Elsevier
La miocarditis es una complicación cardiovascular importante de la COVID-19, enfermedad
producida por el coronavirus de tipo 2 (SARS-CoV-2), causante del síndrome respiratorio …

[PDF][PDF] Role of Ivermectin and Colchicine in Treatment of COVID-19: A Randomized Controlled Clinical Trial

HAESA Salama, EES Ahmed, GEED Amin… - Acta …, 2023 - mattollijournal.org
Objective: To assess the effectiveness of ivermectin and colchicine as treatment options for
COVID-19. Patients and methods: A three-arm randomized controlled clinical trial was …